Corbus Pharmaceuticals Holding Capital Reinvestment Ratio

Latest as of September 2021: 0.01x

Corbus Pharmaceuticals Holding capital reinvestment ratio. Corbus Pharmaceuticals Holding (CRBP) has a Capital Reinvestment Ratio of 0.01x as of September 2021, meaning it reinvests 0% of its operating cash flow ($856.95K) in capital expenditures ($7.70K). Check cash flow reinvestment rate of Corbus Pharmaceuticals Holding to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.01x

Capex / Operating Cash Flow

Operating Cash Flow

$856.95K

USD

Capital Expenditures

$7.70K

USD

Data as of

Sep 2021

Most recent filing

Corbus Pharmaceuticals Holding Capital Reinvestment Ratio by Year (None–None)

Corbus Pharmaceuticals Holding capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see Corbus Pharmaceuticals Holding cash conversion from operations.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow